3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma
32
Melanoma
10
Osteosarcoma
8
Neoplasm Metastasis
8
Sarcoma, Kaposi
6
Leiomyosarcoma
6
Histiocytoma, Malignant Fibrous
6
Chordoma
6
Gliosarcoma
5
Colorectal Neoplasms
5
Carcinosarcoma
5
Carcinoma, Transitional Cell
5
Carcinoma, Renal Cell
5
Carcinoma, Non-Small-Cell Lung
5
Carcinoma, Hepatocellular
5
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Sarcoma, Ewing
4
Neuroblastoma
4
Neoplasms
4
Bone Neoplasms
4
Rhabdomyosarcoma
3
Neurofibrosarcoma
3
Lung Neoplasms
3
Hemangiosarcoma
3
Glioblastoma
3
Gastrointestinal Stromal Tumors
3
Endometrial Neoplasms
3
Desmoid Tumors
3
Cholangiocarcinoma
3
Interventions
tazemetostat
1
relatlimab
1
regorafenib
1
durvalumab
1
brigimadlin
1
bintrafusp alfa protein, human
1
Nivolumab
1
Doxorubicin
1
Clinical Trials, Phase II as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Tertiary Lymphoid Structures
×
Nivolumab
×
Sarcoma
×
Clear all
NCT04095208
2026-04-21
CONGRATS
Institut Bergonié
Phase 2
Completed
68 enrolled